A drug delivery symposium titled Ophthalmic drug delivery: what is currently available and
where are we going? will take place at the Royal Pharmaceutical Society of Great Britain’s
(RPSGB) headquarters in London on Monday 30 June.
Organised by the RPSGB and the Academy of Pharmaceutical Sciences the symposium will
discuss the current and future drug and device combinations on the market to treat diseases of
the eye, and will address issues such as topical and retinal delivery options. There will also be
a discussion on current regulatory trends and points for the industry to consider while
developing drugs and combination products for delivery to the eye.
The event is aimed at managers and scientists from pharmaceutical or device companies, as
well as engineers in pharmaceutical sciences and colleagues from the regulatory, clinical and
medical fields. Academics studying diseases of the eye will also find the meeting beneficial.
Jayne Lawrence, Chief Scientific Advisor at RPSGB, said: “This event will bring together
leading scientists in the field of ophthalmic drug delivery. It will discuss many important issues
and I encourage anyone with an interest in the subject to attend.”
Royal Pharmaceutical Society of Great Britain